In LN229 cells, where most cells die by apoptosis after TMZ, overexpression of RECQL4 variants produced weaker effects on the BLM signal and γH2AX foci in TMZ-treated glioma cells, and the changes were not significant (Fig. 6B,D). The gene discussed is RECQL4; the disease is glioma.